# pathway_0090: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0090.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MAGYLPEPLRMMVTNPAISDFTSDGPLPYALRQKFTGWPPPPAAADISLASQTVLVTGATSGVGLEAARQLAQLGPRLLILGARNLSKADGVKRQLEQDTPHVAVQVAKLDLEDLSSVDRFVDGLHASAIHLDLALLNAGFFANDDRMTPDGYSSLFQVNFLSTAYLAFRLLPLLQTTTTAPEASPQGPRLVLVTSEAHAWTTFPVPPEPAENSLPILSSFRQKESLGSADDQYYRAKLLLALIGKELSRRLTTMQMATSVVITTPGFCASNFFPDSVMTRLIQLISARSIQQGGALHVFAATAQGPQMHGAYLRDGKPTGLSKFAEGPQGQILQQRLWVEMEQFLAGRGYLLSSILKPSSPLQIDGPV

[Multiple Choices]
A. L-threonine biosynthesis
B. Glycolipid biosynthesis
C. Antifungal biosynthesis. .
D. tetrahydrofolate interconversion. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry P9WEG6, annotated as short-chain dehydrogenase rstn4 and assigned to antifungal biosynthesis. The pathway annotation cites ECO:0000269 and PubMed 33857369, supporting the key, though the primary paper was not independently assessed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has features consistent with a short-chain dehydrogenase, but that enzyme-family inference does not identify its pathway; the sequence alone gives no clear basis to select antifungal biosynthesis over the listed alternatives.


**Missing item-specific fact**

> The protein-specific identification as rstn4 in a restricticin biosynthesis cluster and its pathway assignment.


**Reason**

> The supporting pathway annotation is linked to this exact protein and external literature. That item-specific fact is absent from the sequence and choices, and cannot be replaced by generic sequence-based enzyme-family reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence supports C, and the pathway labels are distinct. The issue is that the supplied input does not meaningfully distinguish the options, rather than that multiple options are supported.


### Important caveats

- The sequence match is exact in both the current UniProt entry and the historical entry available by the stated cutoff.
- The UniProt pathway assignment cites experimental evidence, but the primary study was not independently retrieved or validated.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with a short-chain dehydrogenase, but that enzyme-family inference does not identify its pathway; the sequence alone gives no clear basis to select antifungal biosynthesis over the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification as rstn4 in a restricticin biosynthesis cluster and its pathway assignment.",
    "reason": "The supporting pathway annotation is linked to this exact protein and external literature. That item-specific fact is absent from the sequence and choices, and cannot be replaced by generic sequence-based enzyme-family reasoning."
  },
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry P9WEG6, annotated as short-chain dehydrogenase rstn4 and assigned to antifungal biosynthesis. The pathway annotation cites ECO:0000269 and PubMed 33857369, supporting the key, though the primary paper was not independently assessed here."
  },
  "important_caveats": [
    "The sequence match is exact in both the current UniProt entry and the historical entry available by the stated cutoff.",
    "The UniProt pathway assignment cites experimental evidence, but the primary study was not independently retrieved or validated."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports C, and the pathway labels are distinct. The issue is that the supplied input does not meaningfully distinguish the options, rather than that multiple options are supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry P9WEG6, annotated as short-chain dehydrogenase rstn4 and assigned to antifungal biosynthesis. The pathway annotation cites ECO:0000269 and PubMed 33857369, supporting the key, though the primary paper was not independently assessed here.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has features consistent with a short-chain dehydrogenase, but that enzyme-family inference does not identify its pathway; the sequence alone gives no clear basis to select antifungal biosynthesis over the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific identification as rstn4 in a restricticin biosynthesis cluster and its pathway assignment.",
    "reason": "The supporting pathway annotation is linked to this exact protein and external literature. That item-specific fact is absent from the sequence and choices, and cannot be replaced by generic sequence-based enzyme-family reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports C, and the pathway labels are distinct. The issue is that the supplied input does not meaningfully distinguish the options, rather than that multiple options are supported."
  },
  "important_caveats": [
    "The sequence match is exact in both the current UniProt entry and the historical entry available by the stated cutoff.",
    "The UniProt pathway assignment cites experimental evidence, but the primary study was not independently retrieved or validated."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P9WEG6 (sequence matched, 369 AA) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental) from PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' / 'Restricticin biosynthesis cluster protein 4' from Aspergillus nomiae, part of a biosynthetic gene cluster for a CYP51-inhibiting antifungal natural product. The sequence is confirmed as an SDR (Rossmann-fold NAD(P)-binding motif 'GATSGVGLEA' and catalytic tetrad region visible). The expected answer C is directly stated in the database annotation.

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence clearly encodes a short-chain dehydrogenase/reductase (SDR): the N-terminal Rossmann-fold motif (GATSGVGLEA…GARNLSKADG) and the catalytic tetrad region (…TSEAHAWT…YXXXK-like) are recognizable. However, SDRs are ubiquitous across dozens of pathways—homoserine dehydrogenase in threonine biosynthesis (option A), lipid-modifying SDRs in glycolipid pathways (option B), and folate-metabolism SDRs (option D) all share this fold. Nothing in the 369-aa sequence uniquely encodes 'antifungal secondary-metabolite biosynthesis' as opposed to any other SDR-containing pathway.


**Missing item-specific fact**

> The specific biosynthetic gene cluster assignment (rstn4 within the restricticin BGC) and the experimental demonstration that this SDR participates in CYP51-inhibitor (antifungal) biosynthesis (PubMed:33857369). Without knowing the organism, the gene cluster context, or the product identity, the sequence alone cannot distinguish 'antifungal biosynthesis' from glycolipid biosynthesis or other SDR-associated pathways.


**Reason**

> Recognizing the SDR fold narrows the enzyme class but does not identify the pathway. The term 'Antifungal biosynthesis' is a project-specific annotation for a particular secondary-metabolite cluster, not a standard textbook pathway name. Selecting C over A, B, or D requires prior knowledge of this specific protein's role in the restricticin gene cluster, which is an item-specific database/experimental fact absent from the sequence input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Homoserine dehydrogenase (threonine biosynthesis, option A) is itself an SDR with a very similar fold; without additional context a model could reasonably assign an SDR to amino-acid biosynthesis. Similarly, SDRs participate in lipid/glycolipid modification (option B). The wording 'Antifungal biosynthesis' is non-standard and the trailing periods in options C and D add minor formatting noise but do not change the substantive ambiguity among SDR-associated pathways.


### Important caveats

- The UniProt annotation is experimental (ECO:0000269) but the pathway label 'Antifungal biosynthesis' is a project-level grouping, not a canonical KEGG/MetaCyc pathway name.
- The evaluated model was not given the organism name, gene cluster context, or accession; it received only the 369-aa sequence and four pathway labels.
- The entry was first public in Feb 2025; whether it was available in the author's source snapshot is unknown, though the sequence itself is unchanged since version 1.
- The trailing periods in options C and D are cosmetic and do not affect scientific content.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence clearly encodes a short-chain dehydrogenase/reductase (SDR): the N-terminal Rossmann-fold motif (GATSGVGLEA…GARNLSKADG) and the catalytic tetrad region (…TSEAHAWT…YXXXK-like) are recognizable. However, SDRs are ubiquitous across dozens of pathways—homoserine dehydrogenase in threonine biosynthesis (option A), lipid-modifying SDRs in glycolipid pathways (option B), and folate-metabolism SDRs (option D) all share this fold. Nothing in the 369-aa sequence uniquely encodes 'antifungal secondary-metabolite biosynthesis' as opposed to any other SDR-containing pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific biosynthetic gene cluster assignment (rstn4 within the restricticin BGC) and the experimental demonstration that this SDR participates in CYP51-inhibitor (antifungal) biosynthesis (PubMed:33857369). Without knowing the organism, the gene cluster context, or the product identity, the sequence alone cannot distinguish 'antifungal biosynthesis' from glycolipid biosynthesis or other SDR-associated pathways.",
    "reason": "Recognizing the SDR fold narrows the enzyme class but does not identify the pathway. The term 'Antifungal biosynthesis' is a project-specific annotation for a particular secondary-metabolite cluster, not a standard textbook pathway name. Selecting C over A, B, or D requires prior knowledge of this specific protein's role in the restricticin gene cluster, which is an item-specific database/experimental fact absent from the sequence input."
  },
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG6 (sequence matched, 369 AA) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental) from PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' / 'Restricticin biosynthesis cluster protein 4' from Aspergillus nomiae, part of a biosynthetic gene cluster for a CYP51-inhibiting antifungal natural product. The sequence is confirmed as an SDR (Rossmann-fold NAD(P)-binding motif 'GATSGVGLEA' and catalytic tetrad region visible). The expected answer C is directly stated in the database annotation."
  },
  "important_caveats": [
    "The UniProt annotation is experimental (ECO:0000269) but the pathway label 'Antifungal biosynthesis' is a project-level grouping, not a canonical KEGG/MetaCyc pathway name.",
    "The evaluated model was not given the organism name, gene cluster context, or accession; it received only the 369-aa sequence and four pathway labels.",
    "The entry was first public in Feb 2025; whether it was available in the author's source snapshot is unknown, though the sequence itself is unchanged since version 1.",
    "The trailing periods in options C and D are cosmetic and do not affect scientific content."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Homoserine dehydrogenase (threonine biosynthesis, option A) is itself an SDR with a very similar fold; without additional context a model could reasonably assign an SDR to amino-acid biosynthesis. Similarly, SDRs participate in lipid/glycolipid modification (option B). The wording 'Antifungal biosynthesis' is non-standard and the trailing periods in options C and D add minor formatting noise but do not change the substantive ambiguity among SDR-associated pathways."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG6 (sequence matched, 369 AA) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental) from PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' / 'Restricticin biosynthesis cluster protein 4' from Aspergillus nomiae, part of a biosynthetic gene cluster for a CYP51-inhibiting antifungal natural product. The sequence is confirmed as an SDR (Rossmann-fold NAD(P)-binding motif 'GATSGVGLEA' and catalytic tetrad region visible). The expected answer C is directly stated in the database annotation.",
    "evidence_ids": ["C1", "C3", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence clearly encodes a short-chain dehydrogenase/reductase (SDR): the N-terminal Rossmann-fold motif (GATSGVGLEA…GARNLSKADG) and the catalytic tetrad region (…TSEAHAWT…YXXXK-like) are recognizable. However, SDRs are ubiquitous across dozens of pathways—homoserine dehydrogenase in threonine biosynthesis (option A), lipid-modifying SDRs in glycolipid pathways (option B), and folate-metabolism SDRs (option D) all share this fold. Nothing in the 369-aa sequence uniquely encodes 'antifungal secondary-metabolite biosynthesis' as opposed to any other SDR-containing pathway.",
    "missing_item_specific_fact": "The specific biosynthetic gene cluster assignment (rstn4 within the restricticin BGC) and the experimental demonstration that this SDR participates in CYP51-inhibitor (antifungal) biosynthesis (PubMed:33857369). Without knowing the organism, the gene cluster context, or the product identity, the sequence alone cannot distinguish 'antifungal biosynthesis' from glycolipid biosynthesis or other SDR-associated pathways.",
    "reason": "Recognizing the SDR fold narrows the enzyme class but does not identify the pathway. The term 'Antifungal biosynthesis' is a project-specific annotation for a particular secondary-metabolite cluster, not a standard textbook pathway name. Selecting C over A, B, or D requires prior knowledge of this specific protein's role in the restricticin gene cluster, which is an item-specific database/experimental fact absent from the sequence input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Homoserine dehydrogenase (threonine biosynthesis, option A) is itself an SDR with a very similar fold; without additional context a model could reasonably assign an SDR to amino-acid biosynthesis. Similarly, SDRs participate in lipid/glycolipid modification (option B). The wording 'Antifungal biosynthesis' is non-standard and the trailing periods in options C and D add minor formatting noise but do not change the substantive ambiguity among SDR-associated pathways."
  },
  "important_caveats": [
    "The UniProt annotation is experimental (ECO:0000269) but the pathway label 'Antifungal biosynthesis' is a project-level grouping, not a canonical KEGG/MetaCyc pathway name.",
    "The evaluated model was not given the organism name, gene cluster context, or accession; it received only the 369-aa sequence and four pathway labels.",
    "The entry was first public in Feb 2025; whether it was available in the author's source snapshot is unknown, though the sequence itself is unchanged since version 1.",
    "The trailing periods in options C and D are cosmetic and do not affect scientific content."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the protein record, which annotates its pathway as antifungal biosynthesis and cites PubMed 33857369 with experimental evidence code ECO:0000269. This supports the key, although the cited paper was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has a Rossmann-like glycine-rich motif consistent with an NAD(P)-dependent dehydrogenase, but that enzyme-class clue does not identify the pathway in which this particular enzyme acts. Short-chain dehydrogenases occur in diverse metabolic and specialized-metabolite pathways.


**Missing item-specific fact**

> Evidence that this specific enzyme belongs to the antifungal biosynthetic pathway or its biosynthetic gene cluster.


**Reason**

> The sequence can suggest a broad enzyme class, but does not meaningfully distinguish the enzyme’s pathway among the choices. The pathway assignment depends on this protein’s specific biological context, which is not supplied.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No alternative pathway is supported by the supplied sequence alone; the limitation is that the pathway cannot be reliably inferred, not that multiple choices are equally established.


### Important caveats

- The source annotation is sequence-matched and cites experimental evidence, but the underlying publication was not independently assessed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a Rossmann-like glycine-rich motif consistent with an NAD(P)-dependent dehydrogenase, but that enzyme-class clue does not identify the pathway in which this particular enzyme acts. Short-chain dehydrogenases occur in diverse metabolic and specialized-metabolite pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Evidence that this specific enzyme belongs to the antifungal biosynthetic pathway or its biosynthetic gene cluster.",
    "reason": "The sequence can suggest a broad enzyme class, but does not meaningfully distinguish the enzyme’s pathway among the choices. The pathway assignment depends on this protein’s specific biological context, which is not supplied."
  },
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the protein record, which annotates its pathway as antifungal biosynthesis and cites PubMed 33857369 with experimental evidence code ECO:0000269. This supports the key, although the cited paper was not independently reviewed here."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the underlying publication was not independently assessed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No alternative pathway is supported by the supplied sequence alone; the limitation is that the pathway cannot be reliably inferred, not that multiple choices are equally established."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the protein record, which annotates its pathway as antifungal biosynthesis and cites PubMed 33857369 with experimental evidence code ECO:0000269. This supports the key, although the cited paper was not independently reviewed here.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has a Rossmann-like glycine-rich motif consistent with an NAD(P)-dependent dehydrogenase, but that enzyme-class clue does not identify the pathway in which this particular enzyme acts. Short-chain dehydrogenases occur in diverse metabolic and specialized-metabolite pathways.",
    "missing_item_specific_fact": "Evidence that this specific enzyme belongs to the antifungal biosynthetic pathway or its biosynthetic gene cluster.",
    "reason": "The sequence can suggest a broad enzyme class, but does not meaningfully distinguish the enzyme’s pathway among the choices. The pathway assignment depends on this protein’s specific biological context, which is not supplied."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No alternative pathway is supported by the supplied sequence alone; the limitation is that the pathway cannot be reliably inferred, not that multiple choices are equally established."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the underlying publication was not independently assessed."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P9WEG6 (RSTN4_ASPN3) explicitly annotates the PATHWAY as 'Antifungal biosynthesis' with evidence code ECO:0000269|PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' and 'Restricticin biosynthesis cluster protein 4,' part of the restricticin biosynthetic gene cluster producing a CYP51 inhibitor (antifungal natural product). The sequence matches the benchmark input exactly (369 aa, SHA256 matched).

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The specific annotation that this SDR is part of the restricticin biosynthetic gene cluster (a fungal secondary metabolite BGC producing a CYP51 inhibitor). Without knowing this protein's membership in the restricticin BGC, the sequence provides no reliable feature to distinguish 'Antifungal biosynthesis' from the other three options.


**Reason**

> The sequence is identifiable as a short-chain dehydrogenase/reductase (SDR) family member (Rossmann-like NAD(P)-binding motif 'GATSGVGLEAARQLAQL', C-terminal SDR features). However, SDRs are ubiquitous across all four offered pathways: threonine dehydrogenase (A), lipid-modifying SDRs (B), dihydropteridine reductase/folate-related SDRs (D), and SDRs in secondary metabolite BGCs (C). No distinctive sequence motif, domain architecture, or length feature reliably separates a secondary-metabolite BGC SDR from a primary-metabolic SDR. The pathway label 'Antifungal biosynthesis' is a UniProt-specific category for natural product BGCs, not a standard biochemical pathway inferable from sequence features. A model would need to know this exact protein's role in the restricticin BGC to select C over the equally plausible SDR-containing primary metabolic pathways.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While an SDR could theoretically participate in any of the four pathways, the question asks for the PRIMARY pathway, and only the restricticin BGC annotation uniquely assigns this protein to antifungal biosynthesis. The trailing periods in options C and D are minor formatting artifacts that do not create semantic ambiguity.


### Important caveats

- The pathway annotation 'Antifungal biosynthesis' is a UniProt-specific functional category for secondary metabolite biosynthetic gene clusters, not a standard KEGG/MetaCyc pathway name.
- The ECO:0000269 evidence code indicates experimental evidence (from the 2021 JACS paper), not computational transfer.
- The protein's EC number is listed as 1.1.1.- (incomplete), meaning the exact substrate/reaction within the restricticin pathway is not fully characterized.
- Sequence-level SDR family identification is possible but does not resolve the pathway assignment among the four offered choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific annotation that this SDR is part of the restricticin biosynthetic gene cluster (a fungal secondary metabolite BGC producing a CYP51 inhibitor). Without knowing this protein's membership in the restricticin BGC, the sequence provides no reliable feature to distinguish 'Antifungal biosynthesis' from the other three options.",
    "reason": "The sequence is identifiable as a short-chain dehydrogenase/reductase (SDR) family member (Rossmann-like NAD(P)-binding motif 'GATSGVGLEAARQLAQL', C-terminal SDR features). However, SDRs are ubiquitous across all four offered pathways: threonine dehydrogenase (A), lipid-modifying SDRs (B), dihydropteridine reductase/folate-related SDRs (D), and SDRs in secondary metabolite BGCs (C). No distinctive sequence motif, domain architecture, or length feature reliably separates a secondary-metabolite BGC SDR from a primary-metabolic SDR. The pathway label 'Antifungal biosynthesis' is a UniProt-specific category for natural product BGCs, not a standard biochemical pathway inferable from sequence features. A model would need to know this exact protein's role in the restricticin BGC to select C over the equally plausible SDR-containing primary metabolic pathways."
  },
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG6 (RSTN4_ASPN3) explicitly annotates the PATHWAY as 'Antifungal biosynthesis' with evidence code ECO:0000269|PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' and 'Restricticin biosynthesis cluster protein 4,' part of the restricticin biosynthetic gene cluster producing a CYP51 inhibitor (antifungal natural product). The sequence matches the benchmark input exactly (369 aa, SHA256 matched)."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a UniProt-specific functional category for secondary metabolite biosynthetic gene clusters, not a standard KEGG/MetaCyc pathway name.",
    "The ECO:0000269 evidence code indicates experimental evidence (from the 2021 JACS paper), not computational transfer.",
    "The protein's EC number is listed as 1.1.1.- (incomplete), meaning the exact substrate/reaction within the restricticin pathway is not fully characterized.",
    "Sequence-level SDR family identification is possible but does not resolve the pathway assignment among the four offered choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While an SDR could theoretically participate in any of the four pathways, the question asks for the PRIMARY pathway, and only the restricticin BGC annotation uniquely assigns this protein to antifungal biosynthesis. The trailing periods in options C and D are minor formatting artifacts that do not create semantic ambiguity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0090",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG6 (RSTN4_ASPN3) explicitly annotates the PATHWAY as 'Antifungal biosynthesis' with evidence code ECO:0000269|PubMed:33857369 (Liu et al., JACS 2021). The protein is named 'Short chain dehydrogenase rstn4' and 'Restricticin biosynthesis cluster protein 4,' part of the restricticin biosynthetic gene cluster producing a CYP51 inhibitor (antifungal natural product). The sequence matches the benchmark input exactly (369 aa, SHA256 matched).",
    "evidence_ids": ["C5", "C4", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The specific annotation that this SDR is part of the restricticin biosynthetic gene cluster (a fungal secondary metabolite BGC producing a CYP51 inhibitor). Without knowing this protein's membership in the restricticin BGC, the sequence provides no reliable feature to distinguish 'Antifungal biosynthesis' from the other three options.",
    "reason": "The sequence is identifiable as a short-chain dehydrogenase/reductase (SDR) family member (Rossmann-like NAD(P)-binding motif 'GATSGVGLEAARQLAQL', C-terminal SDR features). However, SDRs are ubiquitous across all four offered pathways: threonine dehydrogenase (A), lipid-modifying SDRs (B), dihydropteridine reductase/folate-related SDRs (D), and SDRs in secondary metabolite BGCs (C). No distinctive sequence motif, domain architecture, or length feature reliably separates a secondary-metabolite BGC SDR from a primary-metabolic SDR. The pathway label 'Antifungal biosynthesis' is a UniProt-specific category for natural product BGCs, not a standard biochemical pathway inferable from sequence features. A model would need to know this exact protein's role in the restricticin BGC to select C over the equally plausible SDR-containing primary metabolic pathways."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While an SDR could theoretically participate in any of the four pathways, the question asks for the PRIMARY pathway, and only the restricticin BGC annotation uniquely assigns this protein to antifungal biosynthesis. The trailing periods in options C and D are minor formatting artifacts that do not create semantic ambiguity."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a UniProt-specific functional category for secondary metabolite biosynthetic gene clusters, not a standard KEGG/MetaCyc pathway name.",
    "The ECO:0000269 evidence code indicates experimental evidence (from the 2021 JACS paper), not computational transfer.",
    "The protein's EC number is listed as 1.1.1.- (incomplete), meaning the exact substrate/reaction within the restricticin pathway is not fully characterized.",
    "Sequence-level SDR family identification is possible but does not resolve the pathway assignment among the four offered choices."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P9WEG6",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "aac03b99dd1dc945d40d8e8522a10ed06e2a6d84e2123476329f09b160a2770f",
  "benchmark_sequence_length": 369,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 5,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "current_source_sequence_sha256": "aac03b99dd1dc945d40d8e8522a10ed06e2a6d84e2123476329f09b160a2770f",
  "current_source_sequence_length": 369,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 3,
  "selected_historical_version": {
    "accession": "P9WEG6",
    "database": "Swiss-Prot",
    "entryVersion": 3,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RSTN4_ASPN3",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "ff8c1b64817125a79245574591c776cf54dc0454d7c5b3122875fb82a7084649",
  "selected_historical_source_sequence_sha256": "aac03b99dd1dc945d40d8e8522a10ed06e2a6d84e2123476329f09b160a2770f",
  "selected_historical_source_sequence_length": 369,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 3,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P9WEG6\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":5,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93)\",\"taxonId\":1509407}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein 4\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"1.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Short chain dehydrogenase rstn4\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG6.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG6.json",
  "source_sha256": "0fba683103f8b5ad991b939caaa7539457c1fa5b0a1cdcdff8183c7b2378f85a",
  "retrieved_utc": "2026-11-01T06:25:19.134193+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3",
  "source_sha256": "ff8c1b64817125a79245574591c776cf54dc0454d7c5b3122875fb82a7084649",
  "retrieved_utc": "2026-11-01T06:28:24.829652+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   RSTN4_ASPN3             Reviewed;         369 AA.\nAC   P9WEG6;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 3.\nDE   RecName: Full=Short chain dehydrogenase rstn4 {ECO:0000303|PubMed:33857369};\nDE            EC=1.1.1.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Restricticin biosynthesis cluster protein 4 {ECO:0000303|PubMed:33857369};\nGN   Name=rstn4 {ECO:0000303|PubMed:33857369};\nOS   Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 /\nOS   M93).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=1509407;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3",
  "source_sha256": "ff8c1b64817125a79245574591c776cf54dc0454d7c5b3122875fb82a7084649",
  "retrieved_utc": "2026-11-01T06:28:24.829652+00:00",
  "source_locator": "lines 24-31",
  "excerpt": "RN   [2]\nRP   FUNCTION, AND PATHWAY.\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG6?format=txt&versions=3",
  "source_sha256": "ff8c1b64817125a79245574591c776cf54dc0454d7c5b3122875fb82a7084649",
  "retrieved_utc": "2026-11-01T06:28:24.829652+00:00",
  "source_locator": "lines 47-47",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 90. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
